{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:39:29Z","timestamp":1791823169007,"version":"4.3.4"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    Psilocybin is a serotonergic 5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    R agonist that causes psychedelic and anxiolytic effects in human users. To delineate conservation of psilocybin pharmacology, we investigated behavioral effects of psilocybin in planarians (\n                    <jats:italic toggle=\"yes\">Dugesia dorotocephala<\/jats:italic>\n                    ), the simplest living animal with cephalization that also has a well defined serotonin (5-hydroxytryptamine [5-HT]) system. We quantified stereotyped movements (e.g. head bops, twists, scrunches, and C-shapes) and defensive responding (negative phototaxis) and probed a 5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    R mechanism for psilocybin using a selective 5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    R antagonist (volinanserin). Psilocybin (0.01, 0.1, 1, and 10\u2009nM) increased all stereotyped movements and, at higher concentrations, reduced motility. Volinanserin (1, 10, and 100\u2009nM) did not induce any stereotyped movements or reduce motility. For combination experiments, volinanserin reduced cumulative stereotyped movements produced by psilocybin (0.01\u2009nM) and specifically reduced psilocybin-evoked twists and head bops. Concentrations (&lt;0.01\u2009nM) of psilocybin that did not significantly reduce motility decreased defensive responding (i.e. increased time spent in light side of Petri dish). The reduction in defensive responding by psilocybin (0.01\u2009nM) was prevented by volinanserin (100\u2009nM). Our results show that psilocybin induces stereotypies and anxiolytic-like effects in planarians, likely through mechanisms involving 5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    R, and suggest conservation of certain aspects of psilocybin pharmacology.\n                  <\/jats:p>","DOI":"10.1097\/fbp.0000000000000879","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:00:10Z","timestamp":1779782410000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Psilocybin induces stereotyped movements and reduces defensive responding in planarians through 5-hydroxytryptamine mechanisms"],"prefix":"10.1097","volume":"37","author":[{"given":"Razeen J.","family":"Akbar","sequence":"first","affiliation":[{"name":"Center for Substance Abuse Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy D.","family":"Stringer","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonita","family":"Wiah","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana","family":"Dachepalli","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Daws","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"},{"name":"Department of Neural Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadet","family":"Inan","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"},{"name":"Department of Neural Sciences"},{"name":"Department of Biomedical Education and Data Sciences, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"R1-20260703","doi-asserted-by":"crossref","first-page":"111347","DOI":"10.1016\/j.pnpbp.2025.111347","article-title":"The effect of low-dose psilocybin on brain neurotransmission and rat behavior.","volume":"138","author":"Bysiek","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R2-20260703","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2478\/s11756-013-0147-9","article-title":"Changes of alkaline phosphatase activity in response to different stressors in planarian Dugesia japonica.","volume":"68","author":"Chen","year":"2013","journal-title":"Biologia"},{"key":"R3-20260703","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1068\/p6949","article-title":"Shedding light on photosensitive behaviour in brown planaria (Dugesia tigrina).","volume":"40","author":"Davidson","year":"2011","journal-title":"Perception"},{"key":"R4-20260703","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/03602532.2016.1278228","article-title":"Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.","volume":"49","author":"Dinis-Oliveira","year":"2017","journal-title":"Drug Metab Rev"},{"key":"R5-20260703","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuroscience.2018.06.029","article-title":"Mu opioid receptor agonist DAMGO produces place conditioning, abstinence-induced withdrawal, and naltrexone-dependent locomotor activation in planarians.","volume":"386","author":"Dziedowiec","year":"2018","journal-title":"Neuroscience"},{"key":"R6-20260703","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.physbeh.2014.05.032","article-title":"Tests of unconditioned anxiety - pitfalls and disappointments.","volume":"135","author":"Ennaceur","year":"2014","journal-title":"Physiol Behav"},{"key":"R7-20260703","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00213-014-3739-3","article-title":"Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice.","volume":"232","author":"Fantegrossi","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"R8-20260703","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(83)90464-8","article-title":"Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.","volume":"91","author":"Glennon","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"R9-20260703","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/7854_2016_466","article-title":"Effect of hallucinogens on unconditioned behavior.","volume":"36","author":"Halberstadt","year":"2018","journal-title":"Curr. Top Behav. Neurosci"},{"key":"R11-20260703","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1038\/s41380-023-02274-x","article-title":"Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics.","volume":"28","author":"Jaster","year":"2023","journal-title":"Mol Psychiatry"},{"key":"R12-20260703","doi-asserted-by":"crossref","first-page":"147770","DOI":"10.1016\/j.brainres.2021.147770","article-title":"Nicotine-induced C-shape movements in planarians are reduced by antinociceptive drugs: implications for pain in planarian paroxysm etiology?","volume":"1778","author":"Kim","year":"2022","journal-title":"Brain Res"},{"key":"R13-20260703","doi-asserted-by":"crossref","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","article-title":"Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations.","volume":"33","author":"Kometer","year":"2013","journal-title":"J Neurosci"},{"key":"R14-20260703","doi-asserted-by":"crossref","first-page":"e21756","DOI":"10.1002\/jmor.21756","article-title":"Morphometric analysis and functional insights into the serotonergic system of Girardia tigrina (Tricladida, Platyhelminthes).","volume":"285","author":"Kreshchenko","year":"2024","journal-title":"J Morphol"},{"key":"R15-20260703","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1271\/bbb.90095","article-title":"Effects of Psilocybe argentipes on marble-burying behavior in mice.","volume":"73","author":"Matsushima","year":"2009","journal-title":"Biosci Biotechnol Biochem"},{"key":"R16-20260703","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neures.2007.05.014","article-title":"Identification and distribution of tryptophan hydroxylase (TPH)-positive neurons in the planarian Dugesia japonica.","volume":"59","author":"Nishimura","year":"2007","journal-title":"Neurosci Res"},{"key":"R17-20260703","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1248\/bpb.32.1672","article-title":"Identification of a novel planarian G-protein-coupled receptor that responds to serotonin in Xenopus laevis oocytes.","volume":"32","author":"Nishimura","year":"2009","journal-title":"Biol Pharm Bull"},{"key":"R18-20260703","doi-asserted-by":"crossref","first-page":"113093","DOI":"10.1016\/j.bbr.2020.113093","article-title":"Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.","volume":"401","author":"Odland","year":"2021","journal-title":"Behav Brain Res"},{"key":"R20-20260703","doi-asserted-by":"crossref","first-page":"105046","DOI":"10.1016\/j.neubiorev.2023.105046","article-title":"Utility of preclinical models in the study of psilocybin \u2013 a comprehensive review.","volume":"146","author":"Pedicini","year":"2023","journal-title":"Neurosci Biobehav Rev"},{"key":"R21-20260703","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1176\/appi.ajp.20230172","article-title":"Psychedelics as transformative therapeutics.","volume":"180","author":"Roth","year":"2023","journal-title":"Am J Psychiatry"},{"key":"R22-20260703","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/107385840000600408","article-title":"The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches?","volume":"6","author":"Roth","year":"2000","journal-title":"The Neuroscientist"},{"key":"R23-20260703","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00001756-199612200-00035","article-title":"Identification of planarian serotonin receptor by ligand binding and PCR studies.","volume":"8","author":"Saitoh","year":"1996","journal-title":"Neuroreport"},{"key":"R24-20260703","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1017\/S031716710003537X","article-title":"The brain of the planarian as the ancestor of the human brain.","volume":"12","author":"Sarnat","year":"1985","journal-title":"Can J Neurol Sci"},{"key":"R25-20260703","article-title":"Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists.","author":"Sharp","year":"2025","journal-title":"Br J Pharmacol"},{"key":"R26-20260703","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.alcohol.2014.07.006","article-title":"Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians.","volume":"48","author":"Tallarida","year":"2014","journal-title":"Alcohol"},{"key":"R27-20260703","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vascn.2004.07.002","article-title":"A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria.","volume":"51","author":"Umeda","year":"2005","journal-title":"J Pharmacol Toxicol Methods"},{"key":"R28-20260703","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s43440-023-00550-9","article-title":"The possible place for psychedelics in pharmacotherapy of mental disorders.","volume":"75","author":"Wojtas","year":"2023","journal-title":"Pharmacol Rep"},{"key":"R29-20260703","doi-asserted-by":"crossref","first-page":"e40787","DOI":"10.1371\/journal.pone.0040787","article-title":"Novel RNAi-mediated approach to G protein-coupled receptor deorphanization: proof of principle and characterization of a planarian 5-HT receptor.","volume":"7","author":"Zamanian","year":"2012","journal-title":"PLoS One"},{"key":"R30-20260703","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jneumeth.2017.10.010","article-title":"PLDT (planarian light\/dark test): an invertebrate assay to quantify defensive responding and study anxiety-like effects.","volume":"293","author":"Zewde","year":"2018","journal-title":"J Neurosci Methods"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000879","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:00:22Z","timestamp":1783069222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000879","relation":{},"ISSN":["0955-8810","1473-5849"],"issn-type":[{"value":"0955-8810","type":"print"},{"value":"1473-5849","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"2026-02-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}